Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Escalating Single Intradermal or Subcutaneous Dose Study in Cat Allergic Subjects to Assess the Safety of Cat-PAD.

NCT00685711 is registered in ClinicalTrials.gov with Circassia Limited as lead sponsor.

NCT NCT00685711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00685711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Escalating Single Intradermal or Subcutaneous Dose Study in Cat Allergic Subjects to Assess the Safety of Cat-PAD.
Lead sponsor
Circassia Limited
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2008
Completion date
July 31, 2008
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cat allergy